ID   GCH-nu-YS
AC   CVCL_2910
DR   BioSample; SAMN03470917
DR   BioSample; SAMN03472434
DR   JCRB; JCRB1201
DR   JCRB; NIHS0409
DR   Wikidata; Q54835506
RX   CelloPub=CLPUB00317;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Doubling time: ~35 hours (Note=Lot 04062012) (JCRB=JCRB1201).
CC   Donor information: Established from gestational carcinoma of a woman patient, but the cell line is from the male fetus.
CC   Discontinued: JCRB; NIHS0409; true.
ST   Source(s): JCRB=JCRB1201; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,13
ST   D16S539: 9
ST   D18S51: 15,16,17
ST   D19S433: 13.2,16.2
ST   D21S11: 28,29,31
ST   D2S1338: 17,18,19
ST   D3S1358: 14,17,18
ST   D5S818: 11,12,14
ST   D7S820: 8
ST   D8S1179: 16,17,18
ST   FGA: 19,20
ST   Penta D: 9,9.1,11
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18,19 (JCRB=JCRB1201)
ST   vWA: 17,18,19,20 (PubMed=25877200)
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR87 ! GCH-nu
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   CelloPub=CLPUB00317;
RA   Shimoda T.;
RT   "A study on the cellular proliferation and HCG secretion of
RT   choriocarcinoma cells in hyperthermic condition.";
RL   Kitasato Igakkai Gakkai 12:672-679(1982).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//